Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Basso

Showing results (271-280 of 379) with videos related to

Pageof 38
Sort By:
Journal of Medicinal Chemistry|March 19, 2015
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulinRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Future Medicinal Chemistry|April 16, 2015
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1Francisco Fermín Castro-Navas, Santiago Schiaffino-Ortega, María Paz Carrasco-Jimenez, et al.
Scientific Reports|May 25, 2016
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-ImidazoleRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova ExperienceElisabetta Calore, Piero Marson, Marta Pillon, et al.
British Journal of Haematology|February 28, 2017
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocolBarbara Buldini, Frida Rizzati, Riccardo Masetti, et al.
Redox Biology|March 6, 2022
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cellsMicol Silic-Benussi, Evgenyia Sharova, Francesco Ciccarese, et al.
The Lancet. Oncology|January 17, 2009
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaElaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, et al.
European Journal of Medicinal Chemistry|December 9, 2017
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibitionRomeo Romagnoli, Maria Kimatrai Salvador, Santiago Schiaffino Ortega, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Journal of Hematology & Oncology|October 13, 2020
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencingLorena Zubovic, Silvano Piazza, Toma Tebaldi, et al.
Pageof 38

Showing results (271-280 of 379) with videos related to

Sort By:
Pageof 38
Journal of Medicinal Chemistry|March 19, 2015
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulinRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Future Medicinal Chemistry|April 16, 2015
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1Francisco Fermín Castro-Navas, Santiago Schiaffino-Ortega, María Paz Carrasco-Jimenez, et al.
Scientific Reports|May 25, 2016
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-ImidazoleRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova ExperienceElisabetta Calore, Piero Marson, Marta Pillon, et al.
British Journal of Haematology|February 28, 2017
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocolBarbara Buldini, Frida Rizzati, Riccardo Masetti, et al.
Redox Biology|March 6, 2022
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cellsMicol Silic-Benussi, Evgenyia Sharova, Francesco Ciccarese, et al.
The Lancet. Oncology|January 17, 2009
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaElaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, et al.
European Journal of Medicinal Chemistry|December 9, 2017
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibitionRomeo Romagnoli, Maria Kimatrai Salvador, Santiago Schiaffino Ortega, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Journal of Hematology & Oncology|October 13, 2020
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencingLorena Zubovic, Silvano Piazza, Toma Tebaldi, et al.
Pageof 38